Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Sales | 6,251 | 1,513 |
| Cost of Goods | 2,394 | 486 |
| Gross Profit | 3,857 | 1,027 |
| Operating Expenses | 13,860 | 5,988 |
| Operating Income | -9,609 | -4,475 |
| Interest Expense | 351 | 164 |
| Other Income | 1,315 | 68 |
| Pre-tax Income | -8,645 | -4,571 |
| Net Income Continuous | -8,645 | -4,571 |
| Net Income | $-8,645 | $-4,571 |
| EPS Basic Total Ops | -1.05 | -1.32 |
| EPS Basic Continuous Ops | -1.05 | -1.32 |
| EPS Diluted Total Ops | -1.05 | -1.32 |
| EPS Diluted Continuous Ops | -1.05 | -1.32 |
| EBITDA(a) | $-9,168 | $-4,240 |